Consistent with the mechanism observed in vitro, enhanced p38MAPK and JNK phosphorylation and increased cleavage of PARP were observed in tumor samples obtained from mice treated with carfilzomib and/or vorinostat in vivo. This evidence concerns the gene MAPK8 and neoplasm.